Asaba H, Hosoya Ki, Takanaga H, Ohtsuki S, Tamura E, Takizawa T, Terasaki T.Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2.J Neurochem. 2000 Nov;75(5):1907-16. PMID: 11032880
Aszalos A, Thompson K, Yin JJ, Ross DD. Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on themultidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp). Anticancer Res. 1999 Mar-Apr;19(2A):1053-64. PMID: 10368654
Bebawy M, Morris MB, Roufogalis BD A continuous fluorescence assay for the study of P-glycoprotein-mediated drugefflux using inside-out membrane vesicles. Anal Biochem 1999 Mar 15;268(2):270-7. PMID: 10075817
Braybrooke JP, Vallis KA, Houlbrook S, Rockett H, Ellmen J, Anttila M, Ganesan TS, Harris AL, Talbot DC. Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine. Cancer Chemother Pharmacol. 2000;46(1):27-34. PMID: 10912574
Chiba P, Ecker G, Schmid D, Drach J, Tell B, Goldenberg S, Gekeler V. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance. Mol Pharmacol. 1996 Jun;49(6):1122-30. PMID: 8649352
Chiodini B, Bassan R, Barbui T. Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells. Leuk Lymphoma. 1999 May;33(5-6):485-97. PMID: 10342576
Collett A, Higgs NB, Sims E, Rowland M, Warhurst G. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2. Pharmacol Exp Ther. 1999 Jan;288(1):171-8. PMID: 9862768
Courtois A, Payen L, Guillouzo A, Fardel O. Up-regulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone.FEBS Lett. 1999 Oct 15;459(3):381-5. PMID: 10526169;
Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos. 1999 Aug;27(8):866-71. PMID: 10421612
Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BG, Taylor CW, Miller TP, Salmon SE. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein andpotential circumvention by addition of verapamil to chemotherapy. J Clin Oncol. 1989 Apr;7(4):415-24. PMID: 2564428
DeGregorio MW, Ford JM, Benz CC, Wiebe VJ. Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance. J Clin Oncol. 1989 Sep;7(9):1359-64.PMID: 2527971
Dey S, Hafkemeyer P, Pastan I, Gottesman MM. A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol.Biochemistry. 1999 May 18;38(20):6630-9. PMID: 1035048
Didier A, Wenger J, Loor F. Decreased uptake of cyclosporin A by P-glycoprotein (Pgp) expressing CEM leukemic cells and restoration of normal retention by Pgp blockers. Anticancer Drugs. 1995 Oct;6(5):669-80. PMID: 8845477
Didier A, Loor F.The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anticancer Drugs. 1996 Sep;7(7):745-51. PMID: 8949985
Dimitroulakos J, Yeger H. HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells. Nat Med. 1996 Mar;2(3):326-33. PMID: 8612233
Fardel O, Lecureur V, Loyer P, Guillouzo A. Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells. Biochem Pharmacol. 1995 May 11;49(9):1255-60. PMID: 7763306
Fardel O, Courtois A, Drenou B, Lamy T, Lecureur V, le Prise PY, Fauchet R. Inhibition of P-glycoprotein activity in human leukemic cells by mifepristone.Anticancer Drugs. 1996 Aug;7(6):671-7.PMID: 8913436
Ford JM, Prozialeck WC, Hait WN. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance. Mol Pharmacol. 1989 Jan;35(1):105-15. PMID: 2563302
Ford JM, Hait WN. Pharmacologic circumvention of multidrug resistance. Cytotechnology. 1993;12(1-3):171-212. PMID: 7765325
Fujita R, Ishikawa M, Takayanagi M, Takayanagi Y, Sasaki K. Enhancement of doxorubicin activity in multidrug-resistant cells by mefloquine. Methods Find Exp Clin Pharmacol. 2000 Jun;22(5):281-4. PMID: 11031728
Golstein PE, Boom A, van Geffel J, Jacobs P, Masereel B, Beauwens R.P-glycoprotein inhibition by glibenclamide and related compounds. Pflugers Arch. 1999 Apr;437(5):652-60. PMID: 10087141
Hait WN, Gesmonde JF, Murren JR, Yang JM, Chen HX, Reiss M. Terfenadine (Seldane): a new drug for restoring sensitivity to multidrug resistant cancer cells. Biochem Pharmacol. 1993 Jan 26;45(2):401-6. PMID: 8094615
Ishikawa M, Fujita R, Takayanagi M, Takayanagi Y, Sasaki K. Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole. Biol Pharm Bull. 2000 Jan;23(1):112-5. PMID: 10706423
Ito T, Yano I, Tanaka K, Inui KI. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1.J Pharmacol Exp Ther. 1997 Aug;282(2):955-60. PMID: 9262363
Jonsson O, Behnam-Motlagh P, Persson M, Henriksson R, Grankvist K. Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity. Biochem Pharmacol. 1999 Dec 1;58(11):1801-6. PMID: 10571255
Kawada M, Umezawa K. Inostamycin, an inhibitor of P-glycoprotein function, interacts specifically with phosphatidylethanolamine. Jpn J Cancer Res. 1995 Sep;86(9):873-8. PMID: 7591966
Kim RB, Wandel C, Leake B, Cvetkovic M, Fromm MF, Dempsey PJ, Roden MM, Belas F, Chaudhary AK, Roden DM, Wood AJ, Wilkinson GR. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Pharm Res. 1999 Mar;16(3):408-14. PMID: 10213372
Kochi S, Takanaga H, Matsuo H, Naito M, Tsuruo T, Sawada Y.Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells. Eur J Pharmacol. 1999 May 21;372(3):287-95.PMID: 10395024;
Lecureur V, Fardel O, Guillouzo A. The antiprogestatin drug RU 486 potentiates doxorubicin cytotoxicity in multidrug resistant cells throughinhibition of P-glycoprotein function.FEBS Lett. 1994 Nov 28;355(2):187-91. PMID: 7982498
Lee CG, Gottesman MM, Cardarelli CO, Ramachandra M, Jeang KT, Ambudkar SV, Pastan I, Dey S. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry. 1998 Mar 17;37(11):3594-601. PMID: 9530286
Lin HL, Liu TY, Wu CW, Chi CW. Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells toPaclitaxel. Br J Cancer. 1999 Oct;81(3):416-22. PMID: 10507765
Loo TW, Clarke DM. Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism. J Natl Cancer Inst. 2000 Jun 7;92(11):898-902. PMID: 10841824
Matsuzaki J, Yamamoto C, Miyama T, Takanaga H, Matsuo H, Ishizuka H, Kawahara Y, Kuwano M, Naito M, Tsuruo T, Sawada Y. Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier. Biopharm Drug Dispos. 1999 Mar;20(2):85-90. PMID: 10206323
Mazzanti R, Croop JM, Gatmaitan Z, Budding M, Steiglitz K, Arceci R, Arias IM. Benzquinamide inhibits P-glycoprotein mediated drug efflux and potentiates anticancer agent cytotoxicity in multidrug resistant cells. Oncol Res. 1992;4(8-9):359-65. PMID: 1362504
Mickisch GH, Merlino GT, Galski H, Gottesman MM, Pastan I. Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance.Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):547-51. PMID: 1671173
Mickisch GH, Noordzij MA, v d Gaast A, Gebreamlack P, Kohrmann KU, Mogler-Drautz E, Kupper H, Schroder FH. Dexverapamil to modulate vinblastine resistance in metastatic renal cell carcinoma. J Cancer Res Clin Oncol. 1995;121 Suppl 3:R11-6. PMID: 8698736
Miyake N, Fujita R, Ishikawa M, Takayanagi M, Takayanagi Y, Sasaki K. Reversal of multidrug resistance in human leukemia K562 by tamolarizine, a novel calcium antagonist. Jpn J Pharmacol. 2000 Mar;82(3):265-8. PMID: 10887958
Murren JR, Durivage HJ, Buzaid AC, Reiss M, Flynn SD, Carter D, Hait WN. Trifluoperazine as a modulator of multidrug resistance in refractory breast cancer. Cancer Chemother Pharmacol. 1996;38(1):65-70.PMID: 8603454
Naito M, Oh-hara T, Yamazaki A, Danki T, Tsuruo T. Reversal of multidrug resistance by an immunosuppressive agent FK-506. Cancer Chemother Pharmacol. 1992;29(3):195-200. PMID: 1370765
Phung-Ba V, Warnery A, Scherman D, Wils P. Interaction of pristinamycin IA with P-glycoprotein in human intestinal epithelial cells. Eur J Pharmacol. 1995 Jan 16;288(2):187-92. PMID: 7720780
Plouzek CA, Ciolino HP, Clarke R, Yeh GC. Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract. Eur J Cancer. 1999 Oct;35(10):1541-5. PMID: 10673984
Polli JW, Jarrett JL, Studenberg SD, Humphreys JE, Dennis SW, Brouwer KR, Woolley JL. Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor.Pharm Res. 1999 Aug;16(8):1206-12. PMID: 10468021
Profit L, Eagling VA, Back DJ. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1protease inhibitors. AIDS. 1999 Sep 10;13(13):1623-7. PMID: 10509562
Sarkar MA. Quercetin not only inhibits P-glycoprotein efflux activity but also inhibits CYP3A isozymes. Cancer Chemother Pharmacol. 1995;36(5):448-50 PMID: 7634387.
Schwarz UI, Gramatte T, Krappweis J, Berndt A, Oertel R, von Richter O, Kirch W. Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans.Clin Pharmacol Ther. 1999 Mar;65(3):283-90. PMID: 10096260
Shen DW, Lu YG, Chin KV, Pastan I, Gottesman MM. Human hepatocellular carcinoma cell lines exhibit multidrug resistance unrelated to MRD1 gene expression.J Cell Sci. 1991 Mar;98 ( Pt 3):317-22. PMID: 1676033
Szabo D, Szabo G Jr, Ocsovszki I, Aszalos A, Molnar J. Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo.Cancer Lett. 1999 May 3;139(1):115-9. PMID: 10408903
Takanaga H, Ohnishi A, Matsuo H, Sawada Y. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.Biol Pharm Bull. 1998 Oct;21(10):1062-6. PMID: 9821810
Takanaga H, Ohnishi A, Yamada S, Matsuo H, Morimoto S, Shoyama Y, Ohtani H, Sawada Y. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. J Pharmacol Exp Ther. 2000 Apr;293(1):230-6. PMID: 10734174
Takanaga H, Murakami H, Koyabu N, Matsuo H, Naito M, Tsuruo T, Sawada Y.Efflux transport of tolbutamide across the blood-brain barrier. J Pharm Pharmacol. 1998 Sep;50(9):1027-33. PMID: 9811164
Takano M, Hasegawa R, Fukuda T, Yumoto R, Nagai J, Murakami T. Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells. Eur J Pharmacol. 1998 Oct 9;358(3):289-94 PMID: 9822896;
Takara K, Tanigawara Y, Komada F, Nishiguchi K, Sakaeda T, Okumura K Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs. Biol Pharm Bull 1999 Dec;22(12):1355-9. PMID: 10746169
Terao T, Hisanaga E, Sai Y, Tamai I, Tsuji A. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier. Pharm Pharmacol. 1996 Oct;48(10):1083-9. PMID: 8953513
Tiberghien F, Kurome T, Takesako K, Didier A, Wenandy T, Loor F. Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter.J Med Chem. 2000 Jun 29;43(13):2547-56.PMID: 10891114
Toffoli G, Simone F, Corona G, Raschack M, Cappelletto B, Gigante M, Boiocchi M. Structure-activity relationship of verapamil analogs and reversal of multidrug resistance. Biochem Pharmacol. 1995 Oct 12;50(8):1245-55. PMID: 7488241
Uhr M, Steckler T, Yassouridis A, Holsboer F. Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption.Neuropsychopharmacology. 2000 Apr;22(4):380-7. PMID: 10700657
Vaidyanathan S, Boroujerdi M. Effect of tamoxifen pretreatment on the pharmacokinetics, metabolism and cardiotoxicity of doxorubicin infemale rats. Cancer Chemother Pharmacol. 2000;46(3):185-92. PMID: 11021735
Varga A, Nugel H, Baehr R, Marx U, Hever A, Nacsa J, Ocsovszky I, Molnar J.Reversal of multidrug resistance by amitriptyline in vitro. Anticancer Res. 1996 Jan-Feb;16(1):209-11. PMID: 8615610
von Moltke LL, Greenblatt DJ. Drug transporters in psychopharmacology--are they important?J Clin Psychopharmacol. 2000 Jun;20(3):291-4. PMID: 10831014;
Wacher VJ, Wu CY, Benet LZ. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.Mol Carcinog. 1995 Jul;13(3):129-34. PMID: 7619215;
Wandel C, Kim RB, Guengerich FP, Wood AJ. Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.Drug Metab Dispos. 2000 Aug;28(8):895-8. PMID: 10901697
Wigler PW. PSC833, cyclosporin A, and dexniguldipine effects on cellular calcein retention and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.Biochem Biophys Res Commun. 1999 Apr 13;257(2):410-3. PMID: 10198227;
Wils P, Phung-Ba V, Warnery A, Lechardeur D, Raeissi S, Hidalgo IJ, Scherman D. Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. Biochem Pharmacol. 1994 Oct 7;48(7):1528-30. PMID: 7945455
Wilson WH, Bates SE, Fojo A, Chabner BA. Modulation of multidrug resistance by dexverapamil in EPOCH-refractory lymphomas. J Cancer Res Clin Oncol. 1995;121 Suppl 3:R25-9. PMID: 8698739
Wu X, Whitfield LR, Stewart BH. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter. Pharm Res. 2000 Feb;17(2):209-15. PMID: 10751037
Yacyshyn BR, Bowen-Yacyshyn MB, Pilarski LM. Inhibition by rapamycin of P-glycoprotein 170-mediated export from normal lymphocytes. Scand J Immunol. 1996 Apr;43(4):449-55. PMID: 8668925
Yamazaki M, Suzuki H, Sugiyama Y. Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics Pharm Res. 1996 Apr;13(4):497-513. PMID: 8710738
11/20/00